New FDA Warning

A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.

Related Videos
Related Content

Physical and Mental Health Status in Bipolar Disorder Based on Smoking Status

March 23rd 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: March 13-17

March 18th 2023

Four Myths About Lamotrigine

August 3rd 2021

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

6 Months of Continuing Medical Education

March 11th 2023

Physical and Mental Health Status in Bipolar Disorder Based on Smoking Status

March 23rd 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: March 13-17

March 18th 2023

Four Myths About Lamotrigine

August 3rd 2021

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

6 Months of Continuing Medical Education

March 11th 2023

Physical and Mental Health Status in Bipolar Disorder Based on Smoking Status

March 23rd 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Week in Review: March 13-17

March 18th 2023

Four Myths About Lamotrigine

August 3rd 2021

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

6 Months of Continuing Medical Education

March 11th 2023
© 2023 MJH Life Sciences

All rights reserved.